These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 7173571

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.
    Gilmore IT, Thompson RP.
    Gut; 1978 Dec; 19(12):1110-5. PubMed ID: 744496
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
    Hino K, Yamamoto S, Yamashita S, Fukushima K, Ohashi K.
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2197. PubMed ID: 7328844
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical significance of serum bile acid determination in liver diseases].
    Siciliano M, Lorenzin F, Milani A, Rossi L.
    Ann Ital Med Int; 1990 Nov; 5(2):134-9. PubMed ID: 2248862
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Effect of ursodeoxycholic acid (UDCA) therapy for compensatory liver cirrhosis on liver function tests and serum bile acid metabolism].
    Nakamura K, Aoshima M, Tani M, Kato T, Fugita M, Kimura A, Hasegawa T, Akiyama K, Makino I.
    Nihon Shokakibyo Gakkai Zasshi; 1992 Dec; 89(12):2762-70. PubMed ID: 1491464
    [Abstract] [Full Text] [Related]

  • 32. [Radioimmunoassay of serum bile acid contents--preliminary evaluation and clinical application of the kit].
    Nishino M, Naruki Y, Otsuka S.
    Kaku Igaku; 1982 Aug; 19(7):1077-85. PubMed ID: 7176204
    [No Abstract] [Full Text] [Related]

  • 33. [Fasting and postprandial serum bile acids in chronic liver diseases].
    Testa R, Dellepiane F, Rovida S, Lapertosa G, Domina AR, Virdis MG, Risso D, Mansi C, Picciotto A, Savarino V, Celle G.
    Minerva Dietol Gastroenterol; 1982 Aug; 28(3):195-200. PubMed ID: 7145170
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Significance of serum ferritin measurement by radioimmunoassay in liver diseases].
    Wang QL, Tan TZ, Liang ZL.
    Zhonghua Nei Ke Za Zhi; 1986 Nov; 25(11):649-51, 700. PubMed ID: 3568851
    [No Abstract] [Full Text] [Related]

  • 36. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ, Liaw YF.
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [Abstract] [Full Text] [Related]

  • 37. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H, Beppu T, Seyama Y, Wada T.
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.